The United States is witnessing a rapid transformation in life sciences research, with protein analysis becoming a central pillar of modern biomedical innovation. Increasing focus on disease mechanism understanding, biomarker discovery, and targeted therapeutic development is accelerating adoption of advanced proteomics technologies across academic, clinical, and pharmaceutical settings. Continuous improvements in analytical instrumentation and bioinformatics tools are further strengthening research capabilities across the country. The US Proteomics Market is expanding steadily, supported by rising investments in precision medicine, growing prevalence of chronic diseases, and strong research and development activities in biotechnology and pharmaceuticals. The country’s well established healthcare infrastructure and presence of leading life science companies are also contributing to the accelerated adoption of proteomics based solutions. Growing Burden of Chronic Diseases...